Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine- Results from Two Global Phase 3 Clinical Trials
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1413
https://www.valueinhealthjournal.com/article/S1098-3015(18)31719-4/fulltext
Title :
Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients with Migraine- Results from Two Global Phase 3 Clinical Trials
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31719-4&doi=10.1016/j.jval.2018.04.1413
First page :
Section Title :
Open access? :
No
Section Order :
658